XML 78 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income $ 48,292 $ 38,062 $ 25,170
Reconciliations of net income to net cash provided by operating activities:      
Depreciation and amortization 3,886 4,219 5,452
Non-cash operating lease expense 6,991    
Investment (accretion) amortization and (gains) losses recognized 1,117 163 (51)
Losses recognized on sale of property   64  
Deferred income taxes 2,656 (1,192) 4,039
Share-based compensation 7,173 5,502 4,184
Changes in certain operating assets and liabilities:      
Trade accounts receivable (11,964) (14,933) (10,180)
Income taxes (5,738) 6,089 (4,727)
Prepaid expenses and other (1,039) (8,156) (1,825)
Accounts payable 1,657 (830) 222
Accrued payroll, payroll taxes and related benefits 17,858 (21,863) 28,529
Other accrued liabilities (11,720) 12,550 1,350
Workers' compensation claims liabilities 25,477 49,632 57,140
Safety incentives liability (1,260) 678 3,697
Operating lease liabilities (6,242)    
Other assets and liabilities, net (7) (201) (141)
Net cash provided by operating activities 77,137 69,784 112,859
Cash flows from investing activities:      
Purchase of property, equipment and software (10,798) (5,679) (3,687)
Proceeds from sale of property   485  
Purchase of investments (54,343) (1,946) (6,283)
Proceeds from sales and maturities of investments 88,771 1,885 10,718
Purchase of restricted investments (9,812) (108,739) (381,207)
Proceeds from sales and maturities of restricted investments 52,495 74,650 55,482
Net cash provided by (used in) investing activities 66,313 (39,344) (324,977)
Cash flows from financing activities:      
Proceeds from credit-line borrowings 18,843 8,500 24,899
Payments on credit-line borrowings (18,843) (8,500) (24,899)
Payments on long-term debt (221) (220) (221)
Common stock repurchased on vesting of stock awards (3,136) (2,952) (1,673)
Dividends paid (8,208) (7,348) (7,276)
Proceeds from exercise of stock options 754 577 163
Net cash used in financing activities (10,811) (9,943) (9,007)
Net increase (decrease) in cash, cash equivalents and restricted cash 132,639 20,497 (221,125)
Cash, cash equivalents and restricted cash, beginning of period 140,702 120,205 341,330
Cash, cash equivalents and restricted cash, end of period $ 273,341 $ 140,702 $ 120,205